1. Basu, S. Radioimmunoassay of 8-iso-prostaglandin F2alpha. An index for oxidative injury via free radical catalysed lipid peroxidation. Prost. Leuk. Ess. Fatty Acids, 1998, 58, 319-325.
2. Basu, S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha. An index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prost. Leuk. Ess. Fatty Acids, 1998, 58,347-352.
3. Basu, S. and M. Eriksson. Oxidative injury and survival during endotoxemia. FEBS Letters, 1998, 438, 159-160.
4. Basu, S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem. Biophys. Res. Commun. 1999, 254, 764-767.
5. Basu, S., A. Nozari, X.L. Liu, S. Rubertsson, and L. Wiklund. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Letters, 2000, 470,1-6.
6. Basu, S., K. Michaelsson, H. Olofsson, S. Johansson and H. Melhus. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 2001, 288, 275-279.
7. Basu, S., A. Hellberg, T. Ulus, J. Westman and S. Karacagil. Biomarkers of oxidative injury during spinal cord ischemia. FEBS Lett., 2001, 508, 36-38.
8. Helmersson, J., B.Vessby, A. Larsson and S. Basu. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation, 2004, 109, 1729-1734.
9. Kadiiska, M.B., B. C. Gladen, D. B. Baird, L. B. Graham, C. E. Parker, A. B. N. Ames, S. Basu, G. A. Fitzgerald, J. A. Lawson, L. J. Marnett, J. D. Morrow, D. M. Murray, J. Plastaras, L. J. Roberts, M. K. Shigenaga, J. Sun, P. B. Walter, K. B. Tomer, J. C. Barrett and R. P. Mason. III. Biomarkers of Oxidative Stress Study: Effect of NSAIDs Indomethacin and Meclofenamic acid on Measurements of Oxidative Products of Lipids in CCl4 Poisoning. Free Radical Biology and Medicine, 2005, 38, 711-718.
10. Kadiiska, M.B., B. C. Gladen, D. B. Baird, D. Germolec, L. B. Graham, C. E. Parker, A. Nyska, J. T. Wachsman, B. N. Ames, S. Basu, N. Brot, G. A. Fitzgerald, R. A. Floyd, M. George, J. W. Heinecke, G. H. Hatch, K. Hensley, J. A. Lawson, L. J. Marnett, J. D. Morrow, D. M. Murray, J. Plastaras, L. J. Roberts, M. K. Shigenaga, R. S. Sohal, J. Sun, R. R. Tice, D. H. Van Thiel, D. Wellner, P. B. Walter, K. B. Tomer, R. P. Mason and J. C. Barrett. II. Biomarkers of Oxidative Stress Study: Are Oxidation Products of Lipids, Proteins and DNA Markers in CCl4 Poisoning? Free Radical Biology and Medicine, 2005, 38, 698-710.
11. Basu S. Novel cyclooxygenase-catalysed bioactive prostaglandin F2alpha from physiology to new principles in inflammation. Medicinal Research Reviews 2007, 27, 435-468.
12. Basu S. F2-Isoprostanes in human health and diseases: From molecular mechanisms to clinical implications. Antioxidants and Redox Signaling, 2008, 10, 1405-1434.
Copyright © Pro Ox AB | Grönviken 29 755 94 Uppsala SWEDEN | +46 (0)70 677 40 92 | alex.basu@prooxbio.com